GSK says key trial data shows its RSV vaccine is ‘truly exceptional’
The trial, which involved roughly 25,000 adults aged 60 years and more, tested a single dose of the experimental vaccine against a…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.